Curing HCV with direct-acting antiviral (DAA) treatment: adherence and rapid onset of HCV-RNA undetectability after 4 weeks of treatment with sofosbuvir/velpatasvir - Flamm, S L; Foster, G R; Bourliere, M
American Association for the Study of Liver Diseases: The Liver Meeting; November 4–8, 2022; Washington, DC